2015

On Thursday, September 17, 2015, the United States Senate Subcommittee on Primary Health and Retirement Security held a hearing on…

A recent article honed in on how regulations and market forces facing the pharmaceutical industry affect the way sales…

Yesterday, Democratic Presidential candidate Hillary Clinton proposed a new plan to address pharmaceutical “price…

One of the only major bipartisan moments in recent Congressional history is the physician-backed repeal of the…

Recently, the American Board of Anesthesiology (ABA) announced it will become the first medical board to restructure its…

President Barack Obama has nominated the Food and Drug Administration's Dr. Robert Califf, the current Deputy Commissioner for…

The American Conference Institute's 8th Annual Forum on Sunshine Act, Open Payments, and Aggregate Spend Compliance will…

On September 9, the Deputy Attorney General Sally Quilliam Yates issued a memo entitled “Individual Accountability for Corporate…

Last week, MedPAC (the Medicare Payments Advisory Commission), an important advisory committee to congress, held their…

Pushes for Lower Drug Prices Through Variety of Measures Including Drug Pricing Transparency; Allowing Part D Negotiations;…